RegeneRx Biopharmaceuticals, Inc. (RGRX)

RGRX Revenue

RegeneRx Biopharmaceuticals had revenue of $19.19K in the quarter ending March 31, 2023, a decrease of -0.01%. This brings the company's total for the last twelve months to $76.76K. In the year 2022, RegeneRx Biopharmaceuticals had annual revenue of $76.76K. That makes RegeneRx Biopharmaceuticals the 46,269th largest company in the world by revenue and 6,869th in the United States.

• Revenue (ttm): 76.76K
• Revenue Growth: -0.00%
• P/S Ratio: 3.40
• Revenue / Employee: 25.59K
• Employees: 3
• Market Cap: 260.99K

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	76.76K	-	-
Dec 31, 2021	76.76K	-	-
Dec 31, 2020	76.76K	-1.00	-
Dec 31, 2019	76.76K	7.10K	10.18%
Dec 31, 2018	69.67K	13.02K	22.97%

Data Source: S&P Global Market Intelligence Last updated: May 15, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error